Crawford Investment Counsel’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-10,000
Closed -$82K 260
2018
Q1
$82K Hold
10,000
﹤0.01% 257
2017
Q4
$89K Hold
10,000
﹤0.01% 251
2017
Q3
$111K Hold
10,000
﹤0.01% 243
2017
Q2
$90K Hold
10,000
﹤0.01% 239
2017
Q1
$79K Buy
+10,000
New +$81.5K ﹤0.01% 243

Other funds holding NEO

Crawford Investment Counsel's NEO Position: Q2 2018 in Review

Crawford Investment Counsel sold out of NeoGenomics (NEO) in Q2 2018, closing a stake of 10,000 shares — an estimated $82K sold.

Crawford Investment Counsel first reported a position in NEO in Q1 2017 and held it in 5 quarters. The position peaked at $111K in Q3 2017. 148 funds tracked by Wall St. Rank hold NEO as of Q2 2018.

  • Crawford Investment Counsel reported no remaining NeoGenomics position as of Q2 2018 after selling out during the quarter.
  • Crawford Investment Counsel sold 10,000 NeoGenomics shares in Q2 2018, an estimated $82K.
  • Crawford Investment Counsel first reported a position in NeoGenomics in Q1 2017 and held it in 5 quarters.
  • Crawford Investment Counsel's NeoGenomics position peaked at $111K in Q3 2017.
  • 148 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2018.

Based on Crawford Investment Counsel's 13F filing for Q2 2018, filed 14 Aug 2018.